Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Akebia Therapeutics, Inc. (AKBA)

0.7087 +0.0003 (+0.04%)
As of 2:58:42 PM EST. Market Open.
AKBA Q3 2026 earnings call
November 5, 2026 at 8 AM EST
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Assets
376,565
220,670
241,703
356,054
Total Liabilities Net Minority Interest
343,955
269,855
272,287
350,824
Total Equity Gross Minority Interest
32,610
-49,185
-30,584
5,230
Total Capitalization
80,860
-10,492
-13,401
39,308
Common Stock Equity
32,610
-49,185
-30,584
5,230
Capital Lease Obligations
3,548
8,947
13,438
33,705
Net Tangible Assets
-26,434
-108,229
-125,670
-125,898
Working Capital
90,017
32,917
18,279
55,646
Invested Capital
80,860
-10,492
4,099
71,308
Tangible Book Value
-26,434
-108,229
-125,670
-125,898
Total Debt
51,798
47,640
48,121
99,783
Share Issued
265,424.8180
224,848.9920
194,582.5390
184,135.7140
Ordinary Shares Number
265,424.8180
224,848.9920
194,582.5390
184,135.7140
12/31/2022 - 3/20/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: